| Style | Citing Format |
|---|---|
| MLA | Ghasemi F, et al.. "Tenofovir-Associated Acute Kidney Disease: Is It Different in Hiv- and Hbv-Infected Patients?." American Journal of Therapeutics, vol. 26, no. 5, 2019, pp. E639-E641. |
| APA | Ghasemi F, Salehi M, Rad NK, Khalili H (2019). Tenofovir-Associated Acute Kidney Disease: Is It Different in Hiv- and Hbv-Infected Patients?. American Journal of Therapeutics, 26(5), E639-E641. |
| Chicago | Ghasemi F, Salehi M, Rad NK, Khalili H. "Tenofovir-Associated Acute Kidney Disease: Is It Different in Hiv- and Hbv-Infected Patients?." American Journal of Therapeutics 26, no. 5 (2019): E639-E641. |
| Harvard | Ghasemi F et al. (2019) 'Tenofovir-Associated Acute Kidney Disease: Is It Different in Hiv- and Hbv-Infected Patients?', American Journal of Therapeutics, 26(5), pp. E639-E641. |
| Vancouver | Ghasemi F, Salehi M, Rad NK, Khalili H. Tenofovir-Associated Acute Kidney Disease: Is It Different in Hiv- and Hbv-Infected Patients?. American Journal of Therapeutics. 2019;26(5):E639-E641. |
| BibTex | @article{ author = {Ghasemi F and Salehi M and Rad NK and Khalili H}, title = {Tenofovir-Associated Acute Kidney Disease: Is It Different in Hiv- and Hbv-Infected Patients?}, journal = {American Journal of Therapeutics}, volume = {26}, number = {5}, pages = {E639-E641}, year = {2019} } |
| RIS | TY - JOUR AU - Ghasemi F AU - Salehi M AU - Rad NK AU - Khalili H TI - Tenofovir-Associated Acute Kidney Disease: Is It Different in Hiv- and Hbv-Infected Patients? JO - American Journal of Therapeutics VL - 26 IS - 5 SP - E639 EP - E641 PY - 2019 ER - |